Success Metrics

Clinical Success Rate
87.1%

Based on 81 completed trials

Completion Rate
87%(81/93)
Active Trials
11(8%)
Results Posted
33%(27 trials)
Terminated
12(8%)

Phase Distribution

Ph phase_4
43
30%
Ph not_applicable
16
11%
Ph early_phase_1
1
1%
Ph phase_1
8
6%
Ph phase_2
24
17%
Ph phase_3
47
33%

Phase Distribution

9

Early Stage

24

Mid Stage

90

Late Stage

Phase Distribution139 total trials
Early Phase 1First-in-human
1(0.7%)
Phase 1Safety & dosage
8(5.8%)
Phase 2Efficacy & side effects
24(17.3%)
Phase 3Large-scale testing
47(33.8%)
Phase 4Post-market surveillance
43(30.9%)
N/ANon-phased studies
16(11.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.3%

81 of 95 finished

Non-Completion Rate

14.7%

14 ended early

Currently Active

11

trials recruiting

Total Trials

143

all time

Status Distribution
Active(22)
Completed(81)
Terminated(14)
Other(26)

Detailed Status

Completed81
unknown26
Terminated12
Not yet recruiting9
Recruiting7
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
143
Active
11
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.7%)
Phase 18 (5.8%)
Phase 224 (17.3%)
Phase 347 (33.8%)
Phase 443 (30.9%)
N/A16 (11.5%)

Trials by Status

enrolling_by_invitation21%
active_not_recruiting43%
terminated128%
unknown2618%
completed8157%
not_yet_recruiting96%
recruiting75%
withdrawn21%

Recent Activity

Clinical Trials (143)

Showing 20 of 143 trialsScroll for more
NCT07320534Phase 4

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Terminated
NCT07850414Not Applicable

Intracameral Levofloxacin Versus Moxifloxacin After Cataract Surgery

Not Yet Recruiting
NCT04502095Phase 4

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Completed
NCT06568484Phase 2

Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

Recruiting
NCT05250050Phase 4

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Withdrawn
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07696819Not Applicable

Rationale of Subcutaneous Levofloxacin Infiltration as an Adjunct for Surgical Site Infection Prevention in Emergency Laparotomy

Not Yet Recruiting
NCT03828201Phase 2

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Active Not Recruiting
NCT07528417Phase 2

Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)

Not Yet Recruiting
NCT06494072Phase 4

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Recruiting
NCT02701608Phase 3

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Completed
NCT04951986Phase 3

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Active Not Recruiting
NCT03594149Phase 3

Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Completed
NCT05079620Phase 4

Early Antibiotics After Aspiration in ICU Patients

Terminated
NCT07229755Phase 2

Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria

Completed
NCT03850379Phase 2

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

Completed
NCT07198685Not Applicable

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

Not Yet Recruiting
NCT07150065Phase 2

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Completed
NCT06649721Phase 3

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

Active Not Recruiting
NCT07126639Not Applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
143